Dutch Pharmaceuticals & Biotech Profitable Climbers

Pharming Group

Market Cap: €704.5m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.